Erythrocyte anti-oxyenzyme activity in preterm infants with retinopathy of prematurity

Ren-Huei Fu1, Tsung-Hong Chiu, Ming-Chou Chiang

  • 1Graduate Institute of Clinical Medical Sciences, Chang Gung Children's Hospital, Chang Gung University, Taoyuan, Taiwan.

Neonatology
|June 29, 2007
PubMed

Insights

Reduced glutathione peroxidase activity in preterm infants is linked to retinopathy of prematurity (ROP). Lower enzyme activity may indicate a higher risk for this condition, impacting infant vision.

Area of Science:

  • Neonatal ophthalmology
  • Biochemistry
  • Pediatric critical care

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of visual impairment in premature infants.
  • ROP is a multifactorial disease with complex underlying mechanisms.
  • Antioxidant mechanisms in erythrocytes share similarities with the human retina.

Purpose of the Study:

  • To measure erythrocyte anti-oxyenzyme activity in preterm infants.
  • To investigate the relationship between erythrocyte enzyme activity and ROP development.

Main Methods:

  • Prospective study conducted at a tertiary referral hospital.
  • Blood samples collected from 33 preterm infants within 24 hours of birth.
  • Erythrocyte anti-oxyenzyme activity was evaluated, alongside clinical data and oxygen administration; correlations with ROP status were examined.

Main Results:

  • Preterm infants diagnosed with ROP exhibited significantly lower gestational age, birth weight, 1-minute Apgar scores, and cellular glutathione peroxidase activity.
  • No significant correlation was found between enzyme activity and gestational age, birth weight, or ROP severity.
  • Cumulative oxygen and ventilator administration showed no differences between groups.

Conclusions:

  • Gestational age, birth weight, 1-minute Apgar score, and glutathione peroxidase activity are identified as risk factors for ROP.
  • Defective glutathione peroxidase activity is implicated as a potential contributor to the early stages of ROP development.
Abstract